Conquering Diseases

Study Of Investigational Drugs For People Hospitalized With Covid-19

Description

Seeking men and women hospitalized with COVID-19 for a study of an investigational drug combination.

Overview

We are studying whether an investigational drug combination is safe and effective for patients hospitalized with COVID-19. The investigational drug combination has previously been studied for use in a different infectious disease called Ebola. Participants will either get an injection of the investigational drug or saltwater (placebo).

What we're hoping for

We hope to evaluate whether the investigational drug combination is safe and effective for people hospitalized with COVID-19.

Additional Information

ClinicalTrials.gov Identifier: NCT04492475

 Principal Investigator

Robert  Finberg, MD

University of Massachusetts Medical School

 Study Contact

Jaclyn  Longtine

508-856-5472

Jaclyn.Longtine@umassmed.edu

 Location

UMMS University Campus

55 Lake Ave North 

Worcester,MA 01655

508-856-8989